After Heart Attack: Encouraging Stem Cells To Regenerate Damaged Muscle Interview with
Dr. Takuji Toyama MD
Division of Cardiology
Gunma Prefectural Cardiovascular Center
Maebashi, Japan.

MedicalResearch: What are the main findings of the study?

Dr. Toyama: The early start of granulocyte colony-stimulating factor (G-CSF) therapy in acute myocardial infarction ( AMI) patients can improve myocardial perfusion, fatty acid metabolism and cardiac function in subacute and follow-up periods.

MedicalResearch: What should clinicians and patients take away from your report?

Dr. Toyama: Clinicians should try to use G-CSF in the treatment of acute myocardial infarction.

MedicalResearch: What recommendations do you have for future research as a result of this study?

Dr. Toyama: In the future, we need to study the long-term effects of G-CSF in a large
number of patients with acute myocardial infarction.


Is the granulocyte colony-stimulating factor therapy in the earliest phase effective to rescue patients with acute myocardial infarction?

Takuji Toyama1, Hiroshi Hoshizaki1, Hakuken Kan1, Ren Kawaguchi1, Hitoshi Adachi1, Shigeru Ohsima1, Masahiko Kurabayashi2; 1Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Japan, 2Department of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan.

Presented at the

2014 Society of Nuclear Medicine and Molecular Imaging